WuXi Biologics

Established in 2010, WuXi Biologics has swiftly positioned itself as a global leader in biologics development and manufacturing. Their comprehensive biologics solutions, covering discovery, development, and manufacturing, empower clients to advance their innovations with efficiency and precision. By fostering an environment that encourages collaboration and innovation, they ensure the rapid and cost-effective development of biologics that can transform healthcare outcomes.

Located in Wuxi, Jiangsu, WuXi Biologics employs approximately 12,435 professionals dedicated to advancing biologics development. Under the leadership of Dr. Chris Chen, the company has expanded its reach and capabilities, offering integrated solutions tailored to meet the diverse needs of the biopharmaceutical industry. Their commitment to leveraging cutting-edge technology and expertise positions them as a preferred partner for companies seeking to navigate the complexities of biologics development.

WuXi Biologics prides itself on its state-of-the-art facilities and comprehensive service offerings, ensuring a seamless progression from concept to commercialisation. Their focus on innovation and quality assurance underscores their dedication to client success. By integrating world-class research and development with scalable manufacturing solutions, WuXi Biologics continues to drive forward the future of biologics and revolutionise the way biopharmaceutical products are developed and manufactured worldwide.